Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Am J Reprod Immunol. 2017 Nov 30;79(3):10.1111/aji.12790. doi: 10.1111/aji.12790

Figure 2. Senescence activation.

Figure 2

(A) C12FDG fluorescence was increased in TNF-α treated amnion cells. SB203580 co-treatment inhibited this change, confirming this p38-mediated effect. (B) LPS treatment also increased C12FDG fluorescence to a lesser degree, which was also inhibited by SB203580 co-treatment. (C) Amnion cells exposed to CSE had the largest increase in C12FDG fluorescence. SB203580 inhibited change, confirming a p38-mediated effect. (D) Senescence-associated β-Galactosidase staining was shown in TNF-α, LPS and CSE treated amnion cells, confirming the C12FDG fluorescence results.